Description

Graftide-S 360 Tablet DR (often searched as Graftide 350 mg) is an oral delayed-release immunosuppressant medication manufactured by Mylan Pharmaceuticals Pvt Ltd (a Viatris company). It contains Mycophenolate Sodium (360mg) (which equates to roughly 350mg of active mycophenolic acid). It is primarily prescribed to patients undergoing organ transplantation—most commonly kidney transplants—to prevent acute organ rejection